None listed
Conditions
Interventions
None listed
Sponsors
Ministry of Health, Labor and Welfare
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Cases of Japanese males and females aged 20 to less than 65 and who meet each of the following conditions: 1) One eye group: Those who have an eyeball fistula or corrected vision of 0.02 or less in one eye and do not meet the criteria for recognition of visual impairment of persons with physical disabilities (the criteria after the revision in July 2018) (that is, correction of the other eye) Patients with visual acuity of 0.7 or more) 2) Blepharospasm group: Blepharospasm severity classification Grade 3 to 5 eyelid convulsions, but those who do not meet the criteria for recognition of visual impairment of the physically disabled and patients in the stable period after treatment. 3) Control group: A person who meets the 6th grade of the certification criteria for the physically handicapped person with visual impairment, or a visually impaired person (regardless of the name of eye disease) who falls under the 6th certification criteria.
Exclusion criteria
Exclusion criteria: Those who meet any of the following conditions are not eligible. 1) New patient 2) Those with significant changes in symptoms and findings 3) Since it is a visual impairment-related ADL survey, it is handicapped, deaf, dementia, etc., and if a substitute is required for a deputy 4) Those who have obtained a certificate of the physically disabled other than visually impaired 5) Those who cannot understand the content and procedures of this research 6) Those who are participating in other research 7) Persons who have difficulty visiting the hospital 8) In addition, those who are judged to be ineligible to carry out this research safely by the principal investigator or researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The post-rush conversion scores of LVFDL and LVADL as LVFAM for activities of daily living of the visually impaired. Comparison is made between the one-eye group and the control group, and the blepharospasm group and the control group, respectively. | — |
Countries
Japan
Contacts
Public ContactHirotaka Yokouchi
Chiba University Graduate School of Medicine Ophthalmology
Outcome results
None listed